Latest news
Serodus ASA – Notice of postponement
AGM 2022 to be postponed until late june 2022
2021 Annual Report
SERODUS ASA – Publishes 2021 Annual Report
Q1 2022 Reporting
Highlights
- SER150 clinical study in Australia is still delayed after Covid19 lockdowns
- Serodus received Australian governmental refund (RDTI) for the SER150 Cl-009 study activities.
- The Group qualified for and received a “Patent Voucher” from the Ministry of Commerce in Denmark supporting the patent strategy of the subsidiary Phlogo ApS.
Go to the report: Serodus ASA QR 2022 – Q1
2020 Annual Report
SERODUS ASA – Publishes 2020 Annual Report